NCT01060787View on ClinicalTrials.gov

Evaluation of Corneal Endothelial Cell Density in Subjects Who Have Had a Fluocinolone Acetonide Implant

CompletedOBSERVATIONAL
Enrollment

98

Participants

Timeline

Start Date

February 4, 2016

Primary Completion Date

March 7, 2019

Study Completion Date

June 7, 2019

Conditions
InflammationUveitis
Interventions
PROCEDURE

Fluocinolone Acetonide 0.59 mg

At a single visit bilateral endothelial microscopy will be performed to determine endothelial cell density.

PROCEDURE

Fluocinolone Acetonide 2.1 mg

At a single visit bilateral endothelial microscopy will be performed to determine endothelial cell density.

Trial Locations (1)

02114

Ophthalmic Partners of Boston, Boston

All Listed Sponsors
lead

Bausch & Lomb Incorporated

INDUSTRY

NCT01060787 - Evaluation of Corneal Endothelial Cell Density in Subjects Who Have Had a Fluocinolone Acetonide Implant | Biotech Hunter | Biotech Hunter